7.2.3.3  In the event that th e Adverse Analytical Finding  relates to Prohibited Substances  described in the International Standard for Results Management (such as salbutamol, formoterol or other Prohibited Substance subject to specific Results Management requirements in a Technical Document  or other document issued by WADA ), the ITA shall act in accordance with the requirements set forth in the International Standard for Results  Management.